CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Products | $ 16,961 | $ 27,743 | $ 32,585 | $ 33,343 |
| Costs and Expenses | ||||
| Costs of revenue | 28,608 | 61,524 | 52,723 | 70,912 |
| Research, development and manufacturing operations | 622,921 | 506,001 | 1,174,593 | 1,113,231 |
| Selling, general and administrative | 1,032,825 | 1,611,438 | 1,990,676 | 2,671,489 |
| Share-based compensation | 404,219 | 185,702 | 615,726 | 444,928 |
| Depreciation and amortization | 17,442 | 18,651 | 34,352 | 39,408 |
| Impairment loss | 524,481 | |||
| Total Costs and Expenses | 2,106,015 | 2,383,316 | 3,868,070 | 4,864,449 |
| Loss from Operations | (2,089,054) | (2,355,573) | (3,835,485) | (4,831,106) |
| Other Income/(Expense) | ||||
| Other income/(expense), net | 37,395 | (37,988) | 124,781 | 26,333 |
| Warrant settlement (Note 10) | (743,459) | (743,459) | ||
| Interest expense | (12,159) | (307,081) | (27,410) | (433,635) |
| Total Other Income/(Expense) | 25,236 | (1,088,528) | 97,371 | (1,150,761) |
| Income/(Loss) on Equity Method Investments | (1,579) | (1,726) | (1,579) | (1,702) |
| Net Income/(Loss) | $ (2,065,397) | $ (3,445,827) | $ (3,739,693) | $ (5,983,569) |
| Net Income/(Loss) Per Share (Basic) | $ (1.17) | $ (6.76) | $ (2.33) | $ (21.46) |
| Net Income/(Loss) Per Share (Diluted) | $ (1.17) | $ (6.76) | $ (2.33) | $ (21.46) |
| Weighted Average Common Shares Outstanding (Basic) | 1,802,501 | 509,957 | 1,645,767 | 278,769 |
| Weighted Average Common Shares Outstanding (Diluted) | 1,802,501 | 509,957 | 1,645,767 | 278,769 |
| Other Comprehensive Income/(Loss) | ||||
| Foreign currency translation gain/(loss) | $ 5,334 | $ (522) | $ 7,832 | $ (2,234) |
| Net Comprehensive Income/(Loss) | (2,060,063) | (3,446,349) | (3,731,861) | (5,985,803) |
| Products | ||||
| Products | $ 16,961 | $ 27,743 | $ 32,585 | $ 33,343 |
| X | ||||||||||
- Definition Interest Expense, Excluding Warrant Liability No definition available.
|
| X | ||||||||||
- Definition Warrant settlement amount. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|